Literature DB >> 25307034

Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions.

A Sharif1, M Hecking, A P J de Vries, E Porrini, M Hornum, S Rasoul-Rockenschaub, G Berlakovich, M Krebs, A Kautzky-Willer, G Schernthaner, P Marchetti, G Pacini, A Ojo, S Takahara, J L Larsen, K Budde, K Eller, J Pascual, A Jardine, S J L Bakker, T G Valderhaug, T G Jenssen, S Cohney, M D Säemann.   

Abstract

A consensus meeting was held in Vienna on September 8-9, 2013, to discuss diagnostic and therapeutic challenges surrounding development of diabetes mellitus after transplantation. The International Expert Panel comprised 24 transplant nephrologists, surgeons, diabetologists and clinical scientists, which met with the aim to review previous guidelines in light of emerging clinical data and research. Recommendations from the consensus discussions are provided in this article. Although the meeting was kidney-centric, reflecting the expertise present, these recommendations are likely to be relevant to other solid organ transplant recipients. Our recommendations include: terminology revision from new-onset diabetes after transplantation to posttransplantation diabetes mellitus (PTDM), exclusion of transient posttransplant hyperglycemia from PTDM diagnosis, expansion of screening strategies (incorporating postprandial glucose and HbA1c) and opinion-based guidance regarding pharmacological therapy in light of recent clinical evidence. Future research in the field was discussed with the aim of establishing collaborative working groups to address unresolved questions. These recommendations are opinion-based and intended to serve as a template for planned guidelines update, based on systematic and graded literature review, on the diagnosis and management of PTDM. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Clinical research; complication: medical; diabetes: new onset; diabetology; kidney transplantation; metabolic; nephrology, endocrinology; personal viewpoint; posttransplant, metabolic syndrome, obesity; practice, editorial

Mesh:

Year:  2014        PMID: 25307034      PMCID: PMC4374739          DOI: 10.1111/ajt.12850

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  52 in total

1.  Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation.

Authors:  Shazia Shabir; Seema Jham; Lorraine Harper; Simon Ball; Richard Borrows; Adnan Sharif
Journal:  Transpl Int       Date:  2013-01-02       Impact factor: 3.782

2.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

3.  Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation.

Authors:  Yang Gyun Kim; Chun-Gyoo Ihm; Tae Won Lee; Sang Ho Lee; Kyung Hwan Jeong; Ju Young Moon; Joo-Ho Chung; Su Kang Kim; Yeong Hoon Kim
Journal:  Transplantation       Date:  2012-05-15       Impact factor: 4.939

4.  Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus.

Authors:  Beatriz Tavira; Eliecer Coto; Armando Torres; Carmen Díaz-Corte; Beatriz Díaz-Molina; Francisco Ortega; Manuel Arias; Juan M Díaz; Rafael Selgas; Carlos López-Larrea; Marta Ruiz-Ortega; Alberto Ortiz; Elena González; Josep M Campistol; Victoria Alvarez
Journal:  Mol Genet Metab       Date:  2012-01-04       Impact factor: 4.797

5.  Early basal insulin therapy decreases new-onset diabetes after renal transplantation.

Authors:  Manfred Hecking; Michael Haidinger; Dominik Döller; Johannes Werzowa; Andrea Tura; Jinyao Zhang; Hilal Tekoglu; Johannes Pleiner; Thomas Wrba; Susanne Rasoul-Rockenschaub; Ferdinand Mühlbacher; Sabine Schmaldienst; Wilfred Druml; Walter H Hörl; Michael Krebs; Michael Wolzt; Giovanni Pacini; Friedrich K Port; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 10.121

6.  Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant.

Authors:  Ajay K Israni; Jon J Snyder; Melissa A Skeans; Bertram L Kasiske
Journal:  Transpl Int       Date:  2012-04-30       Impact factor: 3.782

Review 7.  Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review.

Authors:  Julio Pascual; Ana Royuela; Cristina Galeano; Marta Crespo; Javier Zamora
Journal:  Nephrol Dial Transplant       Date:  2011-07-22       Impact factor: 5.992

8.  Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.

Authors:  Johannes Werzowa; Manfred Hecking; Michael Haidinger; Felix Lechner; Dominik Döller; Giovanni Pacini; Gunar Stemer; Johannes Pleiner; Sophie Frantal; Marcus D Säemann
Journal:  Transplantation       Date:  2013-02-15       Impact factor: 4.939

9.  Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses.

Authors:  Tone G Valderhaug; Jøran Hjelmesæth; Trond Jenssen; Jo Røislien; Torbjørn Leivestad; Anders Hartmann
Journal:  Transplantation       Date:  2012-10-15       Impact factor: 4.939

Review 10.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

View more
  111 in total

1.  Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data.

Authors:  L S Vest; F M Koraishy; Z Zhang; N N Lam; M A Schnitzler; V R Dharnidharka; D Axelrod; A S Naik; T A Alhamad; B L Kasiske; G P Hess; K L Lentine
Journal:  Clin Transplant       Date:  2018-06-29       Impact factor: 2.863

2.  Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial.

Authors:  Khurram Bari; Shimul A Shah; Tiffany E Kaiser; Robert M Cohen; Nadeem Anwar; David Kleesattel; Kenneth E Sherman
Journal:  Liver Transpl       Date:  2020-08-19       Impact factor: 5.799

3.  Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors.

Authors:  Emily R Perito; Robert H Lustig; Philip Rosenthal
Journal:  J Pediatr       Date:  2016-12-29       Impact factor: 4.406

4.  Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals.

Authors:  Bénédicte Sautenet; Allison Tong; Karine E Manera; Jeremy R Chapman; Anthony N Warrens; David Rosenbloom; Germaine Wong; John Gill; Klemens Budde; Lionel Rostaing; Lorna Marson; Michelle A Josephson; Peter P Reese; Timothy L Pruett; Camilla S Hanson; Donal O'Donoghue; Helen Tam-Tham; Jean-Michel Halimi; Jenny I Shen; John Kanellis; John D Scandling; Kirsten Howard; Martin Howell; Nick Cross; Nicole Evangelidis; Philip Masson; Rainer Oberbauer; Samuel Fung; Shilpa Jesudason; Simon Knight; Sreedhar Mandayam; Stephen P McDonald; Steve Chadban; Tasleem Rajan; Jonathan C Craig
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

Review 5.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

Review 6.  How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.

Authors:  S Fuji; A Rovó; K Ohashi; M Griffith; H Einsele; M Kapp; M Mohty; N S Majhail; B G Engelhardt; A Tichelli; B N Savani
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

7.  Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study.

Authors:  Sandra Aleksic; Ruth Eisenberg; Effie Tsomos; Sara Zahedpour Anaraki; Emily Japp; Laxmi Upadhyay; Wenzhu Bi Mowrey; Enver Akalin; Joel Zonszein
Journal:  Diabetes Res Clin Pract       Date:  2020-05-20       Impact factor: 5.602

8.  Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.

Authors:  Pauline Lancia; Tiphaine Adam de Beaumais; Valéry Elie; Florentine Garaix; Marc Fila; François Nobili; Bruno Ranchin; Pascale Testevuide; Tim Ulinski; Wei Zhao; Georges Deschênes; Evelyne Jacqz-Aigrain
Journal:  Pediatr Nephrol       Date:  2018-02-04       Impact factor: 3.714

Review 9.  Emerging treatments for post-transplantation diabetes mellitus.

Authors:  Trond Jenssen; Anders Hartmann
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

Review 10.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

Authors:  Vijay Shivaswamy; Brian Boerner; Jennifer Larsen
Journal:  Endocr Rev       Date:  2015-12-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.